Prescribing information

 

Prescribing information

Preview a range of resources designed to support you and your GILENYA®▼ (fingolimod) patients during face-to-face or virtual conversations.

This website is intended for healthcare professionals only. Please do not share links to this page with patients. You can download the resources to share with patients separately.

Image of video screengrab

WHAT TO EXPECT WHEN STARTING GILENYA

A video to show your patients what it’s like to start receiving treatment with GILENYA.

Watch

Image of Gilenya patient booklet cover

GILENYA PATIENT BOOKLET

A booklet for your patients who have been prescribed GILENYA, which provides important information about taking GILENYA and practical advice about wellbeing while on treatment.

Download

Image of Young person’s guide to Gilenya

THE YOUNG PERSON’S GUIDE TO GILENYA

A booklet to help your paediatric patients understand more about their treatment.

Download

 

Image of Symtrac app overview

SYMTRAC™

A free app to help your patients keep track of their MS.

Download for Android

Download for Apple

Download leaflet

Image of recognising your MS Symptoms guide

RECOGNISING YOUR MS SYMPTOMS

A guide to help your patients recognise MS symptoms and what to do in case they think they are having a relapse.

Download

Image of MS relapse recorder resource

MS RELAPSE RECORDER

A resource for your patients to record and track their MS symptoms. 

Download

 

Image of Paediatric License: Paradigms Study movie

PAEDIATRIC LICENCE: PARADIGMS STUDY

An animated overview of the PARADIGMS study, a landmark phase III trial of GILENYA in paediatric patients with RRMS. 

Watch

Image of Gilenya Discussion Guide

GILENYA DISCUSSION GUIDE

A guide for you to use in conversations with your patients who have been prescribed GILENYA, but which must not be given or sent to patients. The guide helps you introduce GILENYA and explain information that patients need to know before commencing treatment.

Download

 

Image of patient, parent and caregiver guide

PATIENT, PARENT AND CAREGIVER GUIDE

A booklet for GILENYA patients or their parents or caregivers which explains what GILENYA is and contains other important information about the treatment.

View

Image of pregnancy-specific patient reminder card

PREGNANCY-SPECIFIC PATIENT REMINDER CARD

A card to give to patients to explain the warnings and contraindications related to pregnancy associated with GILENYA.

View

Image of prescribers checklist

PRESCRIBER’S CHECKLIST

A checklist for prescribers listing important points to remember before, during and after a patient has been prescribed GILENYA.

View

 

Image of summary of product characteristics for Gilenya

SUMMARY OF PRODUCT CHARACTERISTICS FOR GILENYA

The summary of product characteristics for GILENYA.

Clicking the View button will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.

View

 

Indication: GILENYA is indicated as a single disease modifying therapy in highly active RRMS for the following groups of adult patients and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with ≥1 disease modifying therapy, or patients with RES RRMS defined by ≥2 disabling relapses in 1 year, and with 1 or more Gd+ lesions on brain MRI or a significant increase in T2 lesion load as compared to a previous recent MRI.1

Gd+, gadolinium-enhancing; HCP, healthcare professional; MRI, magnetic resonance imaging; MS, multiple sclerosis; RES, rapidly evolving severe; RRMS, relapsing-remitting multiple sclerosis.

Reference

  1. GILENYA (fingolimod) Summary of Product Characteristics.
GIL19-C053e(2) November 2020.
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]